Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia?

Citrome, Leslie

Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia? [electronic resource] - Evidence-based mental health 05 2016 - e6 p. digital

Publication Type: Journal Article; Comment

1468-960X

10.1136/eb-2015-102143 doi


Antipsychotic Agents--therapeutic use
Dopamine--therapeutic use
Dopamine Agonists--therapeutic use
Humans
Schizophrenia--drug therapy